Skip to content
value.today

Merck & Co., Inc. vs Samumed

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

Market cap history

$0 M$97.1 B$194.3 B$291.4 B$388.6 B2020202120222023202420252026
● Merck & Co., Inc.● Samumed

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$16B$33B$49B$65B201720182019202020212022202320242025Merck & Co., Inc. $65B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureMerck & Co., Inc.
MRK · #40 in the world
Samumed
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceutical—
Founded19702008
Size
Market cap$359.8 B—
Revenue$65.0 B—
Net income$18.3 B—
Employees75,000—
Valuation
P/E ratio147×—
Price to sales5.3×—
Price to book6.8×—
Free cash flow yield3.4%—
Profitability
Gross margin74.8%—
Net margin28.1%—
Return on equity36.9%—
Growth
Revenue growth1.3%—
Revenue growth, 3 years a year3.1%—
Earnings per share growth8.0%—
Financial strength
Debt to equity0.9×—
Cash
Free cash flow margin19.0%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield3.7%—
Strength scores
Piotroski F-score4 of 9—
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap —

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Sources#

Every figure on this page comes from these, with the date shown next to it.